PlexusDx vs Willow
$189/mo against $399/mo for tirzepatide. Which is worth it, and for whom.
Updated 2026-09-18
Both sell tirzepatide. PlexusDx costs $189 a month and Willow costs $399, a difference of $210 a month or about $2,520 a year. The desk reads it as follows.
PlexusDx is pharmacy transparency and genetic testing. Willow is straightforward single-price plans. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.
Advert against bill. PlexusDx advertises $129 and bills $189; Willow advertises $399 and bills $399. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.
Side by side
| PlexusDx | Willow | |
|---|---|---|
| Advertised | $129 | $399 |
| Billed | $189 | $399 |
| Gap | +$60 | none |
| Per year, billed | $2,268 | $4,788 |
Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.
The split
3 differences on the record. The others match.
| PlexusDx | Willow | |
|---|---|---|
| Price is the same at every dose | Yes | No |
| Names the compounding pharmacy publicly | Yes | No |
| Offers an oral or sublingual option | Yes | No |
What each puts on the record: PlexusDx
- No membership or platform fee is charged alongside the medication.
- Publicly names six 503A pharmacy partners: Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills.
Where it wins: The most detailed pharmacy disclosure in this comparison — six named 503A partners. Watch for: The advertised "from $129" is the programme floor. Budget $189/month for the compounded injection tier.
What each puts on the record: Willow
Where it wins: A single price with no membership arithmetic. Watch for: There is little published detail on how dose changes are handled. Ask before committing.
In each one’s favour
PlexusDx.
- The most detailed pharmacy disclosure in this comparison — six named 503A partners.
- Names its prescribing physicians along with their NPI numbers.
Willow.
- A single price with no membership arithmetic.
PlexusDx scores higher overall at 4.4 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.
The desk’s call
The board says PlexusDx. What the board cannot say is whether the advertised figures you were shown elsewhere match these — check the gap row, because a listing that advertises low and bills high will beat an honest one in any comparison built on advertised prices.
The verdict
On the board, PlexusDx at $189 a month is the more defensible choice on arithmetic alone. Willow earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: PlexusDx and Willow.
How they sit against everyone else
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
More from the desk
- PlexusDx tirzepatide review
Advertised at $129, billed at $189. Position 5 of 18 on our board.
- Willow tirzepatide review
Advertised at $399 and billed at $399 — no gap. Position 15 of 18 on our board.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure
